Search Results 361-370 of 17413 for alopecia
Resolution of treatment-related toxicity to < grade 1; alopecia and cutaneous toxicity are allowed < grade 2; >1 week since palliative RT; Ability to ...
Subjects with vitiligo or alopecia;; Subjects with hypothyroidism (e.g., following Hashimoto syndrome) stable on hormone replacement;; Any chronic skin ...
... Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Vulvar skin disorder, Breast skin change, Rosacea, Pigmentation disorder ...
... . VID-20381363. Home; AsktheMayoMom about Proton Beam Therapy to Treat Children with Brain Tumors. Fuel groundbreaking medical research!
previously administered agent. - Note: individuals with any grade neuropathy or alopecia are an exception to this criterion and will qualify for the study ...
Tests and procedures used to diagnose cutaneous B-cell lymphoma include: Physical exam. Your healthcare professional will carefully check your skin.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19. 5X My Gift! Find a doctor · Explore careers.
Residual chronic toxicities of prior therapy ≤ Grade 2 (eg, peripheral neuropathy, residual alopecia) are allowed. Female subjects who are pre-menopausal ...
- All grades of alopecia are acceptable; - Endocrine dysfunction on replacement therapy is acceptable. - Severe or unstable medical condition, including ...
Patients who have not recovered from adverse events due to prior anti-cancer therapy (i.e., have residual toxicities > Grade 1),with the exception of alopecia, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.